Central Sensitisation and Postoperative Pain
Behavioural and Neurophysiological Measurements for the Assessment of Central Sensitisation and Postoperative Pain
1 other identifier
interventional
70
1 country
2
Brief Summary
One out of 10 patients undergoing surgery develops persistent post-surgical pain (PPSP). Unfortunately, available therapies for treating this pain have limited success. It is therefore of great importance to find strategies to prevent PPSP. The goal of this project is to find new screening tools that identify patients that are at risk for developing PPSP. Tissue injury and inflammation following surgery increase the excitability of spinal nociceptive neurons ("central sensitisation", CS) with pain hypersensitivity as consequence. It is thought that CS plays an important role in persistent pain. The first objective of this project is to assess in human patients if the propensity to develop CS manifested as secondary hyperalgesia before surgery is predictive for PPSP. In addition, we will test if the frequency content of the resting-state EEG reflecting the initial state of the brain will be related to the propensity for developing CS and to the presence of PPSP at two months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2020
CompletedFirst Posted
Study publicly available on registry
January 7, 2020
CompletedStudy Start
First participant enrolled
January 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedOctober 6, 2021
October 1, 2021
2.7 years
January 6, 2020
October 5, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
mechanical pinprick perceived intensity
magnitude of the increase in sensitivity to mechanical pinprick stimuli after HFS
1 day before surgery
area of increased mechanical pinprick sensitivity
spatial extent of the increased sensitivity to mechanical pinprick stimuli after HFS
1 day before surgery
resting state EEG
frequency content of the resting state EEG
1 week before surgery
Study Arms (1)
patients undergo lateral thoracotomy for primary lung cancer
EXPERIMENTAL1. Electroencephalography (EEG) will be acquired before surgery 2. Questionnaires assessing psychological status of the patients before and after surgery 3. High frequency electrical stimulation of the skin (HFS) will be delivered before surgery 4. Quantification of mechanical sensitivity after HFS and after surgery
Interventions
recording of resting state EEG using 64 surface electrodes
Hospital Anxiety Depression Scale (HADS) Neuropathic Pain questionnaire (DN4) Brief Pain Inventory (BPI) Fatigue Assessment Scale (FAS)
HFS consists of transcutaneous electrical stimuli delivered as 42 Hz trains (pulse width: 2 ms) lasting 1 s. The trains are repeated 12 times. Each train is separated by 10 seconds.
Mechanical pinprick stimuli will be applied manually by the operator on the skin using a mechanical stimulator (maximum weight 128 mN).
Eligibility Criteria
You may qualify if:
- Scheduled for a lateral thoracotomy as treatment for primary lung cancer
- Ability to provide written informed consent
You may not qualify if:
- Evidence for a clinically-significant alteration of the skin of the volar forearms
- Pregnancy
- Having a pacemaker or implanted cardiac defibrillator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Surgery
Brussels, 1200, Belgium
Saint Luc Hospital
Brussels, 1200, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valérie Lacroix, MD, PhD
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2020
First Posted
January 7, 2020
Study Start
January 29, 2020
Primary Completion
September 30, 2022
Study Completion
December 31, 2022
Last Updated
October 6, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share